Study finds rare gain for tough-to-treat pancreatic cancer

Study finds rare gain for tough-to-treat pancreatic cancer



Patients with pancreatic cancer that hadn't spread lived substantially longer on a four-drug combo than on a single standard cancer drug, It's a rare advance for a tough-to-beat cancer, and experts say it could be practice-changing for a small group of patients whose pancreatic cancer is diagnosed early enough to be removed by surgery.